Conference

National Real Estate Media Platform, Commercial Observer, Launches ESG Newsletter

Retrieved on: 
Thursday, June 30, 2022 - 12:27am
Jerry Speyer, View, CEO, Observer Media, Carbon, Research, Commercial property, DEI, ESG, Annual conferences, Industry, REBNY, JPMorgan Chase, Development, Wiedemann Wysocki National Finance Council Award, Information services, Corporate governance, Property technology, Real Estate Board of New York, Investment, Blackstone, Social, Biophysical environment, CRE, NYSERDA, Carbon footprint, News, Multimedia, Conference, Property management

NEW YORK, June 29, 2022 /PRNewswire/ -- Commercial Observer, the premier media and information services company that informs and connects leaders in the commercial real estate industry, has announced the launch of ESG Insights, a monthly newsletter encompassing the latest news and trends surrounding Environmental, Social & Corporate Governance (ESG) in the commercial real estate industry.

Key Points: 
  • NEW YORK, June 29, 2022 /PRNewswire/ -- Commercial Observer, the premier media and information services company that informs and connects leaders in the commercial real estate industry, has announced the launch of ESG Insights, a monthly newsletter encompassing the latest news and trends surrounding Environmental, Social & Corporate Governance (ESG) in the commercial real estate industry.
  • The launch of the monthly newsletter aligns with Commercial Observer's commitment and recent investments dedicated to expanding ESG coverage through new products, partnerships and events.
  • Commercial Observer is also a supporter of the Commercial Real Estate FInance Council (CREFC) June 2022 Annual Conference's opening ESG session with JPMorgan Chase and Blackstone.
  • Commercial Observer is the leading commercial real estate media and information services company, delivering high-impact content, events and platforms designed to connect and inform industry participants of key trends and people defining the global real estate landscape.

Toll Brothers Arizona Wins Five Grand Awards at PCBC

Retrieved on: 
Wednesday, June 29, 2022 - 11:23pm
Morrison Ranch, Agoura Hills, California, Nicklaus Design, Engineering, GLOBE, Company, Industry, Association, PCBC, California Building Industry Association, Toll Brothers, New, District, NYSE, Xavier Gold Rush and Gold Nuggets, Grand Award Records, White Tank Mountains, Builder, Professional Builder, Creativity, Conference, Interior design, Building, Citrus, Amusement park

Among its many accolades, Toll Brothers home designs were recognized for Best Indoor/Outdoor Lifestyle and Best Home/Work Space.

Key Points: 
  • Among its many accolades, Toll Brothers home designs were recognized for Best Indoor/Outdoor Lifestyle and Best Home/Work Space.
  • In addition, Toll Brothers won Masterplan Community of the Year for its Sterling Grove community in Surprise, Arizona.
  • Toll Brothers honors the legacy of the land with tree-lined streets, citrus groves, water courses, and cornerstone parks.
  • Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse the products or services of, Toll Brothers.

AMMO, Inc. Reports Fiscal Year 2022 Financial Results Including 285% Revenue Growth and Provides Fiscal Year 2023 Guidance Comprising of $300 Million to $310 Million in Revenues

Retrieved on: 
Wednesday, June 29, 2022 - 9:05pm
Depreciation, Forest Law Enforcement and Governance Program, Acquisition, Red Army Standard Ammunition, EBITDA, Workforce, GLOBE, Growth, Ownership, Law enforcement, Sale, Company, Goal, Â, POWW, GAAP, Firearm, AMMO, Gun, Nasdaq, EPS, GunBroker.com, Risk, Federal, Conference, Report, Form 8-K, Bookkeeping, Health insurance, Video game, Renewable energy, Weapon, Marketplace, Adjustment

2022 Fiscal Year versus 2021 Fiscal Year:

Key Points: 
  • 2022 Fiscal Year versus 2021 Fiscal Year:
    Net Revenues increased 285% to $240.3 million.
  • For perspective, AMMO delivered 400 million rounds of loaded ammunition in 2022, which has pushed us to capacity at our current facility.
  • Total net revenues for the year ended March 31, 2022, increased 285% or $177.8 million over the year ended March 31, 2021.
  • Management will host a conference call to discuss the Companys Full Fiscal Year 2022 results at 5:00 p.m.

Hyperfine Announces CEO Transition

Retrieved on: 
Wednesday, June 29, 2022 - 9:05pm
FDA, Patient, CEO, Caregiver, Paola Lattus, Adoption, GLOBE, Marketing, COVID-19, Growth, Company, U.S. Securities and Exchange Commission, Interim, Magnetic resonance imaging, Partnership, Humanitarian use licenses, Investor, Traction, Technology, Private Securities Litigation Reform Act, High-dependency unit, Board, Leadership, MRI, Income, Security (finance), Conference, Management, Pharmaceutical industry, Medical imaging, Renewable energy, Swoop, Nasdaq, Hyperfine structure

GUILFORD, Conn., June 29, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), (“Hyperfine” or “the Company”), the groundbreaking medical device company that created Swoop®, the world's first FDA-cleared portable MRI system™, today announced that Dave Scott will step down from his role as President, Chief Executive Officer (CEO), and Board Member for personal reasons, effective July 29, 2022. Scott Huennekens, who currently serves as Executive Chairperson of the Board, will succeed Mr. Scott as interim President and CEO, also effective July 29, 2022. The Company is engaging in a search for a long-term CEO as it continues to execute its business strategy focused on commercial expansion of the Swoop system. The Company will host a conference call to discuss the CEO transition today, June 29, 2022, at 4:30 PM Eastern Time.

Key Points: 
  • The Company will host a conference call to discuss the CEO transition today, June 29, 2022, at 4:30 PM Eastern Time.
  • As interim President and CEO, Mr. Huennekens will oversee the ongoing expansion of Hyperfine to become a leading medical imaging provider.
  • We wish him well as he addresses the personal reasons limiting his ability to continue as President and CEO of Hyperfine.
  • I am disappointed to have to step back from my role as President and CEO of Hyperfine.

Mirion Technologies to Present at CJS Securities’ 22nd Annual “New Ideas” Summer Conference

Retrieved on: 
Wednesday, June 29, 2022 - 9:15pm
Defense, Security, Technology, Other Technology, Software, Other Defense, Hardware, GA, Solution, News, NYSE, MIR, Research, Radiation, Conference, CJS, Technology, Medical imaging

Mirion Technologies, Inc. (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at CJS Securities 22nd Annual New Ideas Summer Conference in Greenwich, CT on Tuesday, July 12, 2022.

Key Points: 
  • Mirion Technologies, Inc. (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at CJS Securities 22nd Annual New Ideas Summer Conference in Greenwich, CT on Tuesday, July 12, 2022.
  • Mirion Technologies is a leading provider of detection, measurement, analysis and monitoring solutions to the nuclear, defense, medical and research end markets.
  • The organization aims to harness its unrivaled knowledge of ionizing radiation for the greater good of humanity.
  • Many of the company's end markets are characterized by the need to meet rigorous regulatory standards, design qualifications and operating requirements.

AMERISAFE Announces 2022 Second Quarter Earnings Release and Conference Call Schedule

Retrieved on: 
Wednesday, June 29, 2022 - 10:00pm
Professional Services, Insurance, Human Resources, Agriculture, Insurance, Internet, Company, Webcast, Conference, Nasdaq

AMERISAFE, Inc. (Nasdaq: AMSF), a specialty provider of workers compensation insurance focused on high hazard industries, today announced it will release its 2022 second quarter financial results on Thursday, July 28, 2022 after the market closes.

Key Points: 
  • AMERISAFE, Inc. (Nasdaq: AMSF), a specialty provider of workers compensation insurance focused on high hazard industries, today announced it will release its 2022 second quarter financial results on Thursday, July 28, 2022 after the market closes.
  • In conjunction with the release, the Company has scheduled a conference call which will be broadcast live over the Internet on Friday, July 29, 2022 at 10:30AM Eastern time.
  • AMERISAFE, Inc. is a specialty provider of workers compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, agriculture, and manufacturing.
  • AMERISAFE actively markets workers compensation insurance in 27 states.

NOW Inc. Announces Second Quarter 2022 Earnings Conference Call

Retrieved on: 
Wednesday, June 29, 2022 - 9:15pm
Utilities, Construction & Property, Oil, Gas, Other Manufacturing, Energy, Engineering, Other Construction & Property, Manufacturing, View, Digital, Engineering, Mining, Information management, Access Now, Inc. v. Southwest Airlines Co., Financial result, Investor relations, NYSE, Solution, Webcast, NOW, Conference, Video game

NOW Inc. (NYSE:DNOW) has scheduled a conference call to discuss the results for the second quarter of 2022 on Wednesday, August 3, 2022 at 8:00 am (US Central Time).

Key Points: 
  • NOW Inc. (NYSE:DNOW) has scheduled a conference call to discuss the results for the second quarter of 2022 on Wednesday, August 3, 2022 at 8:00 am (US Central Time).
  • Financial results for the second quarter ending on June 30, 2022 are expected to be released that morning before the market opens.
  • The call will be broadcast through the Investor Relations link on NOW Inc.s web site at ir.dnow.com on a listen-only basis.
  • Participants may also join the conference call by dialing 1-833-927-1758 within North America or 1-929-526-1599 outside of North America, Access Code: 990303, five to ten minutes prior to the scheduled start time and asking for the NOW Inc. Earnings Conference Call or the DistributionNOW Earnings Conference Call.

Century Communities Sets Date for Second Quarter 2022 Earnings Release and Conference Call

Retrieved on: 
Wednesday, June 29, 2022 - 9:05pm
Review, Investor, CCS, Company, Community, Conference, NYSE, Mobile phone

GREENWOOD VILLAGE, Colo., June 29, 2022 /PRNewswire/ --Century Communities, Inc. (NYSE: CCS), a leading national homebuilder, today announced that the Company will release its second quarter 2022 financial results after the market closes on Wednesday, July 27, 2022.

Key Points: 
  • GREENWOOD VILLAGE, Colo., June 29, 2022 /PRNewswire/ --Century Communities, Inc. (NYSE: CCS), a leading national homebuilder, today announced that the Company will release its second quarter 2022 financial results after the market closes on Wednesday, July 27, 2022.
  • A conference call will be held that same day at 5:00 p.m. Eastern time, 3:00 p.m. Mountain time, to review the Company's second quarter results, discuss recent events and conduct a question-and-answer session.
  • The conference call will be available in the Investors section of the Company's website at www.centurycommunities.com .
  • To Participate in the Telephone Conference Call:
    Dial in at least 5 minutes prior to start time:

Lexicon Announces Positive Top-Line Results From Phase 2 Proof-Of-Concept Study Of LX9211 In Painful Diabetic Neuropathy

Retrieved on: 
Wednesday, June 29, 2022 - 9:01pm
Neuropathic pain, Bristol Myers Squibb, Science, Patient, Sex, Protein, Gene, GLOBE, Nausea, Growth, Metabolism, Disease, Intellectual property, U.S. Securities and Exchange Commission, Annual report, Call, Heart failure, CT, Pharmacokinetics, Fast Track, ID, Food, THE, Headache, Security (finance), Diabetic neuropathy, Dizziness, Webcast, Nasdaq, Trial of the century, Trigeminal neuralgia, Form 10-K, ET, Safety, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, AAK1, Drug discovery, Diabetes, Pharmaceutical industry, Lexicon, Conference

THE WOODLANDS, Texas, June 29, 2022 (GLOBE NEWSWIRE) --  Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced top-line results of RELIEF-DPN-1, its Phase 2 proof-of-concept study of LX9211 in painful diabetic neuropathy. LX9211 achieved the primary endpoint of the study, demonstrating a statistically significant reduction in average daily pain score (ADPS) at week 6 compared to placebo in the low dose arm with results that plateaued in the high dose arm.   Separation from placebo was seen by week 1 in both dose arms, and the effect was consistent across age, sex, concurrent use of medications for painful diabetic neuropathy, and baseline pain score.

Key Points: 
  • A full analysis of the results from RELIEF-DPN-1 will be submitted for publication at an upcoming medical conference and in a peer-reviewed journal.
  • LX9211 has received Fast Track designation from the U.S. Food and Drug Administration for the development in diabetic peripheral neuropathic pain.
  • RELIEF-DPN-1 is a Phase 2 randomized, double-blind, placebo-controlled, parallel-group, multicenter study evaluating the efficacy, safety and pharmacokinetics of LX9211 in the treatment of painful diabetic neuropathy, also referred to as diabetic peripheral neuropathic pain.
  • The RELIEF-DPN-1 study is the first of two Phase 2 proof-of-concept studies evaluating LX9211 in neuropathic pain.

PetVivo to Discuss Financial Results for the Fiscal Year End ended March 31, 2022 and Business Update

Retrieved on: 
Wednesday, June 29, 2022 - 9:00pm
Horse, G&A, Research, Expense, MWI, GLOBE, Conference call, Marketing, Sale, EDINA, Company, U.S. Securities and Exchange Commission, Regulation Fair Disclosure, Forward-looking statement, Multichannel Multipoint Distribution Service, Disclosure, Therapy, Total revenue, Forgiveness, Nasdaq, Marginal cost, Investor relations, SEC, Dog, Limp, Animal, Private Securities Litigation Reform Act, Regulation, Paycheck Protection Program, Webcast, Osteoarthritis, Security (finance), Method, Medical device, Online gambling, Spice, Pharmaceutical industry, Risk management, Income, Conference

EDINA, MN, June 29, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, announces financial results for its fiscal year ended March 31, 2022.

Key Points: 
  • Fiscal Year Ended March 31, 2022 (fiscal 2022) Compared to The Year Ended March 31, 2021 (fiscal 2021)
    Total Revenues.
  • Revenues increased to $115,586 in fiscal 2022 compared to $12,578 in fiscal 2021 and consisted of sales to veterinary clinics.
  • Cost of sales was $201,154 in fiscal 2022 compared to $10,695 for fiscal 2021.
  • Operating expenses increased to $4,970,960 in fiscal 2022 compared to $1,960,871 in fiscal 2021.